We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Woodcock Wants Federal Investigation of FDA’s Relationship With Biogen
Woodcock Wants Federal Investigation of FDA’s Relationship With Biogen
Acting FDA Commissioner Janet Woodcock is calling for a wide-ranging federal investigation into her own agency’s actions during the drug approval process with Biogen over its newly approved Alzheimer’s disease drug Aduhelm (aducanumab).